Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

June 14, 2022

Study Completion Date

June 14, 2022

Conditions
Endometrial Cancer Stage IEndometrial Cancer Stage II
Interventions
PROCEDURE

ambulatory surgery

total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy

PROCEDURE

standard surgery

total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy

Trial Locations (9)

75

Service de chirurgie gynécologique, hôpital Tenon, Paris

63003

Service de Chirurgie Gynécologique Obstétrique Reproduction Humaine, Clermont-Ferrand

75013

Service de chirurgie gynécologique, hôpital Pitié-salpêtrière, Paris

75015

HEGP - Chirurgie Cancérologique Gynécologique et du Sein, Paris

75018

Hôpital Bichat-Claude Bernard Gynécologie obstétrique, Paris

94010

CHIC - Gynécologie-Obstétrique-Maternité, Créteil

94805

IGR - Comité d'Oncologie Gynécologique, Villejuif

95600

Service de chirurgie gynécologique, Centre Hospitalier Simone Veil, Eaubonne

Unknown

Service de chirurgie gynécologique, Centre de lutte contre le cancer, Dijon

All Listed Sponsors
collaborator

Ecole d'econmie de Paris (PSE)-Hospinnomics

UNKNOWN

collaborator

Université Montpellier

OTHER

collaborator

Université de Rennes 1 CREM CNRS UMR 6211

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03580421 - Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO) | Biotech Hunter | Biotech Hunter